HUMAW vs ILMN
Humacyte Inc (HUMAW) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
Humacyte Inc (HUMAW) common stock listed on NASDAQ.
Illumina Inc (ILMN) is a diagnostics & research company listed on US. It is led by Jacob Thaysen Ph.D..
HUMAW does not have a complete income-statement cache yet.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. ILMN currently screens at market cap $15.84B.
HUMAW currently screens at market cap $0. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the HUMAW and ILMN stock pages for the full models.
Not investment advice.